PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Valirx Plc | LSE:VAL | London | Ordinary Share | GB00BLH13C52 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.25 | 1.2% | 21.00 | 20.50 | 21.50 | 21.00 | 20.50 | 20.75 | 523,507 | 14:00:07 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 0.0 | -2.7 | -0.3 | - | 14 |
Valirx (VAL) News Headlines
Valirx News
| Date | Time | Source | Headline |
|---|---|---|---|
| 25/2/2021 | 07:00 | UKREG | ValiRx PLC Block listing Interim Review |
| 18/2/2021 | 15:39 | UKREG | ValiRx PLC Director/PDMR Shareholding |
| 15/2/2021 | 11:05 | ALNC |  IN BRIEF: ValiRx Extends Collaboration Agreement With Physiomics |
| 15/2/2021 | 07:00 | UKREG | ValiRx PLC Extension of Collaboration Agreement |
| 19/1/2021 | 16:53 | ALNC | IN BRIEF: ValiRx's VAL201 Patented For Treatment Of Metastatic Cancer |
| 19/1/2021 | 11:36 | UKREG | ValiRx PLC Director Disclosure |
| 19/1/2021 | 07:00 | UKREG | ValiRx PLC Patent Status Update |
| 30/11/2020 | 11:04 | UKREG | ValiRx PLC Holding(s) in Company |
| 30/11/2020 | 07:46 | UKREG | ValiRx PLC VAL201 Clinical Trial Full Data Results |
| 10/11/2020 | 17:40 | ALNC | UK TRADING UPDATE SUMMARY: Newly-Listed Wheaton Reports Bumper Quarter |
1 Year Valirx Chart |
Intraday Valirx Chart |
